### English:
The variant **rs121913279** is a well-documented single nucleotide polymorphism (SNP) associated with the **BRCA1 gene**, which is known for its role in hereditary breast and ovarian cancer. Below is an overview of bioinformatics tools that can analyze this variant:

---

#### 1. **Variant Identification**
- **rs Number**: rs121913279
- **HGVS Notation**: NM_007294.3:c.5266dupC (p.Gln1756ProfsTer25)
- **Gene Name**: BRCA1
- **Transcript Name**: NM_007294.3
- **Links**:
  - [dbSNP rs121913279](https://www.ncbi.nlm.nih.gov/snp/rs121913279)
  - [ClinVar Entry](https://www.ncbi.nlm.nih.gov/clinvar/variation/17661/)

---

#### 2. **Disease Associations**
This variant is classified as **pathogenic** and is strongly associated with **hereditary breast and ovarian cancer syndrome**. It results in a frameshift mutation leading to a truncated BRCA1 protein, which disrupts its tumor suppressor function. Tools for disease association analysis include:
- **ClinVar**: Provides curated clinical significance data ([ClinVar rs121913279](https://www.ncbi.nlm.nih.gov/clinvar/variation/17661/)).
- **AlphaMissense**: Predicts pathogenicity of missense variants, though this specific variant is a frameshift mutation.
- **SIFT/PolyPhen**: Not applicable for frameshift mutations but useful for other types of variants.

---

#### 3. **Literature Evidence**
This variant has been extensively studied in the context of hereditary cancer syndromes. Key publications include:
- Easton et al., 2007: "Genome-wide association study identifies novel breast cancer susceptibility loci."
- Antoniou et al., 2003: "Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations."
- [PubMed Search for rs121913279](https://pubmed.ncbi.nlm.nih.gov/?term=rs121913279)

---

#### 4. **Allele Frequency Comparison**
- **Japanese Population**: This variant is extremely rare or absent in the general Japanese population, as it is primarily observed in individuals with familial cancer syndromes.
- **Non-Japanese Populations**: Found in individuals of European descent with hereditary breast and ovarian cancer. Tools like **gnomAD** and **1000 Genomes** can provide allele frequency data:
  - [gnomAD rs121913279](https://gnomad.broadinstitute.org/variant/rs121913279)

---

#### 5. **GWAS Findings**
This variant is not typically identified in GWAS studies due to its rarity and high penetrance. GWAS tools like **GWAS Catalog** can be used to explore other BRCA1-related phenotypes:
- [GWAS Catalog BRCA1](https://www.ebi.ac.uk/gwas/genes/BRCA1)

---

### Recommended Bioinformatics Tools for Analysis:
1. **ClinVar**: For clinical significance and disease association.
2. **gnomAD**: For population allele frequency.
3. **MutationTaster**: For functional impact prediction.
4. **VarSome**: Integrates multiple databases for variant interpretation ([VarSome rs121913279](https://varsome.com/variant/hg19/rs121913279)).
5. **Ensembl Variant Effect Predictor (VEP)**: For annotation and functional impact analysis ([VEP Tool](https://www.ensembl.org/info/docs/tools/vep/index.html)).

---

### Japanese:
**rs121913279**は、遺伝性乳がんおよび卵巣がんに関連する**BRCA1遺伝子**の変異として広く知られています。この変異を解析するためのバイオインフォマティクスツールについて以下に説明します。

---

#### 1. **変異の識別**
- **rs番号**: rs121913279
- **HGVS表記**: NM_007294.3:c.5266dupC (p.Gln1756ProfsTer25)
- **遺伝子名**: BRCA1
- **転写産物名**: NM_007294.3
- **リンク**:
  - [dbSNP rs121913279](https://www.ncbi.nlm.nih.gov/snp/rs121913279)
  - [ClinVarエントリー](https://www.ncbi.nlm.nih.gov/clinvar/variation/17661/)

---

#### 2. **疾患との関連性**
この変異は**病原性**と分類されており、**遺伝性乳がんおよび卵巣がん症候群**と強く関連しています。フレームシフト変異によりBRCA1タンパク質が短縮され、腫瘍抑制機能が損なわれます。以下のツールが疾患関連性解析に役立ちます：
- **ClinVar**: 臨床的意義のデータを提供 ([ClinVar rs121913279](https://www.ncbi.nlm.nih.gov/clinvar/variation/17661/)).
- **AlphaMissense**: ミスセンス変異の病原性を予測しますが、この変異はフレームシフトのため適用外。
- **SIFT/PolyPhen**: フレームシフト変異には適用されませんが、他の変異には有用。

---

#### 3. **文献証拠**
この変異は遺伝性がん症候群の文脈で広く研究されています。主な文献には以下が含まれます：
- Easton et al., 2007: 「乳がん感受性遺伝子座を特定するゲノムワイド関連解析」
- Antoniou et al., 2003: 「BRCA1またはBRCA2変異に関連する乳がんおよび卵巣がんの平均リスク」
- [PubMedでrs121913279を検索](https://pubmed.ncbi.nlm.nih.gov/?term=rs121913279)

---

#### 4. **アレル頻度の比較**
- **日本人集団**: この変異は日本人集団では非常に稀または存在しないとされています。主に家族性がん症候群の患者で観察されます。
- **非日本人集団**: 遺伝性乳がんおよび卵巣がんを持つヨーロッパ系の個人で見られます。**gnomAD**や**1000 Genomes**などのツールでアレル頻度データを確認できます：
  - [gnomAD rs121913279](https://gnomad.broadinstitute.org/variant/rs121913279)

---

#### 5. **GWASの発見**
この変異は稀で浸透率が高いため、通常GWAS研究では特定されません。GWASツール（例：**GWAS Catalog**）を使用して、BRCA1関連の他の表現型を探索できます：
- [GWAS Catalog BRCA1](https://www.ebi.ac.uk/gwas/genes/BRCA1)

---

### 推奨されるバイオインフォマティクスツール：
1. **ClinVar**: 臨床的意義と疾患関連性の解析。
2. **gnomAD**: 集団アレル頻度の解析。
3. **MutationTaster**: 機能的影響の予測。
4. **VarSome**: 複数のデータベースを統合した変異解釈 ([VarSome rs121913279](https://varsome.com/variant/hg19/rs121913279)).
5. **Ensembl Variant Effect Predictor (VEP)**: 注釈と機能的影響の解析 ([VEPツール](https://www.ensembl.org/info/docs/tools/vep/index.html)).

---